Throughout the pandemic, the U.S. Food and Drug Administration has found many nefarious actors seeking to exploit consumers during the pandemic by selling unproven medical products often with fraudulent claims. The emergence of fraudulent medical products is a common phenomenon during crisis situations. For example, in 2013, the FDA issued 10 warning letters to firms selling unproven medical products with false or misleading claims to protect against influenza. In 2014, 7 warning letters were issued for unproven and fraudulent Ebola products.
The FDA is well-equipped to rapidly identify and thwart medical product scams to protect consumers.
No comments:
Post a Comment